AI Tech Group amends merger agreement; extends closing to Dec 31, 2026, sets $50M minimum raise

AI Technology Group Inc.

Second amendment to merger with AVM Biotechnology and Biomed 360 details investment tranches: $1M (Tranche 1), $1.125M (partial Tranche 2), plus $500K monthly from June to Oct 2026 and $375K in Nov.
Tranche 2 loans are convertible at $2.50/share with 10% simple interest; closing extended to Dec 31, 2026 (extendable to Mar 31, 2027).
Tranche 3 requires at least $50M in gross proceeds before closing, at $5.00/share or higher, with a senior US exchange up‑listing.
All other terms of the original Merger Agreement remain unchanged.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AI Technology Group Inc. entered into Agreement and Plan of Merger with AVM Biotechnology Inc. , a Nevada corporation (“AVM”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”) (effective 2025-09-15).

Action: entry
Agreement: merger
Counterparty: AVM Biotechnology Inc. , a Nevada corporation (“AVM”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”)
Effective: 2025-09-15

Exact text from the filing

On September 15, 2025, AI Technology Group Inc. (the “Corporation”) filed, as Exhibit 10 to its registration statement filed on Form 10-12G, entered into a Agreement and Plan of Merger with AVM Biotechnology Inc. , a Nevada corporation (“AVM”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”).

View on SEC.gov

801 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001477932-26-003844

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.